C1q Deficiency and Autoimmunity: The Effects of Genetic Background on Disease Expression1

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Immunology

• Publication date

  2000-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.168.5.2538PMID 11859149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protection and injury: the differing roles of complement in the development of glomerular injury

  2001cited by this paper
• Complement Component C3 Is Not Required for Full Expression of Immune Complex Glomerulonephritis in MRL/lpr Mice

  2001cited by this paper
• Modulation of Renal Disease in MRL/lpr Mice Genetically Deficient in the Alternative Complement Pathway Factor B1

  2000cited by this paper
• Complement C4 Inhibits Systemic Autoimmunity through a Mechanism Independent of Complement Receptors Cr1 and Cr2

  2000cited by this paper
• Systemic lupus erythematosus, complement deficiency, and apoptosis.

  2000cited by this paper
• A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo

  2000cited by this paper
• Epistatic modifiers of autoimmunity in a murine model of lupus nephritis.

  1999cited by this paper
• Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation.

  1999cited by this paper
• Genetic susceptibility to systemic lupus erythematosus.

  1998cited by this paper
• Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

  1998cited by this paper
• A critical role for complement in maintenance of self-tolerance.

  1998cited by this paper
• Repeat-induced gene silencing in mammals

  1998cited by this paper
• C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited.

  1997cited by this paper
• Polygenic control of susceptibility to murine systemic lupus erythematosus.

  1994cited by this paper
• An MRL/MpJ-lpr/lpr substrain with a limited expansion of lpr double-negative T cells and a reduced autoimmune syndrome.

  1993cited by this paper
• Dexamethasone prevents autoimmune nephritis and reduces renal expression of Ia but not costimulatory signals.

  1992cited by this paper
• Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA.

  1992cited by this paper
• Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease.

  1991cited by this paper
• Subnucleosome structures as substrates in enzyme-linked immunosorbent assays.

  1990cited by this paper
• Differential effect of the autoimmune yaa and ipr genes on the acceleration of lupus‐like syndrome in mrl/mpj mice

  1989cited by this paper
• The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus‐like syndrome in (NZW × C57BL/6)F1 male mice, but not in C57BL/6 male mice

  1988influential reference
• Oligoclonality of rheumatoid factors arising spontaneously in lpr/lpr mice.

  1988cited by this paper
• Measurement of anti-DNA antibodies: a reappraisal using five different methods.

  1987cited by this paper
• Murine models of systemic lupus erythematosus.

  1985cited by this paper
• Induction of various autoantibodies by mutant gene lpr in several strains of mice.

  1984cited by this paper
• Autoimmune and lymphoproliferative disease in (B6-GIX+ X 129)F1 mice: relation to naturally occurring antibodies against murine leukemia virus-related cell surface antigens.

  1979cited by this paper

• C1q limits cystoid edema by maintaining basal β-catenin–dependent signaling and blood-retina barrier function

  2025cites this paper
• Do microenvironmental changes in degenerative disc disease reflect in systemic circulation? A proteomic investigation

  2025cites this paper
• C1q limits cystoid edema by maintaining basal beta-catenin-dependent signaling and blood-retina barrier function

  2025cites this paper
• C1q Binds to CD4+ T Cells and Inhibits the Release of Pro-Inflammatory Cytokines: Role in the Pathogenesis of Systemic Lupus Erythematosus

  2025cites this paper
• Interplay of procoagulatory and neutrophil-derived anticoagulatory proteins in C1q-NET-driven blood coagulation.

  2025cites this paper
• Double-negative B cells and DNASE1L3 colocalise with microbiota in gut-associated lymphoid tissue

  2024cites this paper
• Comprehensive analysis of IRF8-related genes and immune characteristics in lupus nephritis

  2024cites this paper
• Lupus sistémico en niños

  2024cites this paper
• Could tolerance to DNA be broken in the gut in systemic lupus erythematosus?

  2024cites this paper
• Tissue-resident C1q + macrophages exert anti-aging potential through the Sirt1 pathway

  2024cites this paper
• Unanticipated interacting features of human gut-associated lymphoid tissues link microbiota, intestinal immunity and autoimmunity

  2023cites this paper
• Identification of driver genes in lupus nephritis based on comprehensive bioinformatics and machine learning

  2023cites this paper
• Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies

  2022cites this paper
• C1q as a target molecule to treat human disease: What do mouse studies teach us?

  2022cites this paper
• Intertwined pathways of complement activation command the pathogenesis of lupus nephritis.

  2022cites this paper
• Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus

  2022cites this paper
• Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis

  2022cites this paper
• Lupus systémique de l’enfant

  2022cites this paper
• The role of the complement system in kidney glomerular capillary thrombosis

  2022cites this paper
• Expanding the Role of Complement Therapies: The Case for Lupus Nephritis

  2021cites this paper
• Mechanisms of tissue injury in lupus nephritis

  2021cites this paper
• Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?

  2021cites this paper
• Complement Deficiencies Result in Surrogate Pathways of Complement Activation in Novel Polygenic Lupus-like Models of Kidney Injury

  2020cites this paper
• Complement, infection, and autoimmunity.

  2019cites this paper
• Apoptosis and Clearance of Apoptotic Cells

  2019cites this paper
• Complement Therapeutics in Autoimmune Disease

  2019cites this paper
• Epistatic Interactions Between Mutations of Deoxyribonuclease 1-Like 3 and the Inhibitory Fc Gamma Receptor IIB Result in Very Early and Massive Autoantibodies Against Double-Stranded DNA

  2018cites this paper
• Apoptosis and Clearance of Apoptotic Cells.

  2018cites this paper
• C1r/C1s deficiency is insufficient to induce murine systemic lupus erythematosus

  2018cites this paper
• Differential expression of complement subcomponent C 1 qA in blood samples of healthy and BLV-infected Polish Holstein-Friesian cows *

  2018cites this paper
• Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway

  2018cites this paper
• The Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus

  2018cites this paper
• Essential Domain-Dependent Roles Within Soluble IgG for in vivo Superantigen Properties of Staphylococcal Protein A: Resolving the B-Cell Superantigen Paradox

  2018cites this paper
• Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-1/3 in the Development of Lupus-Like Glomerulonephritis in MRL/lpr Mice

  2018cites this paper
• Efferocytosis and autoimmune disease

  2018cites this paper
• Chapter 17 – Innate Immunity

  2017cites this paper
• Chemical Approaches to Modulating Complement-Mediated Diseases.

  2017cites this paper
• MafB is a critical regulator of complement component C1q

  2017cites this paper
• Association between C1q gene polymorphisms and autoimmune thyroid diseases

  2017cites this paper
• Complement Component C1q Programs a Pro-Efferocytic Phenotype while Limiting TNFα Production in Primary Mouse and Human Macrophages

  2016cites this paper
• Animal Models of Autoimmunity

  2016cites this paper
• Anti-DNA Antibodies

  2016cites this paper
• Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity

  2016cites this paper
• Immune factors guiding Listeria monocytogenes infection

  2016cites this paper
• Microvesicles in Autoimmune Diseases.

  2016cites this paper
• The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation

  2016cites this paper
• C1q, antibodies and anti-C1q autoantibodies.

  2015cites this paper
• Clinical presentation of human C1q deficiency: How much of a lupus?

  2015cites this paper
• Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell‐mediated Th17 and Th1 T cell subset proliferation

  2015cites this paper
• The combined effect of sidestream smoke and dynamic shear stress on endothelial cell inflammatory responses.

  2015cites this paper
• Clearance of Apoptotic Bodies, NETs, and Biofilm DNA: Implications for Autoimmunity

  2014cites this paper
• Complement Protein C1q and Adiponectin Stimulate Mer Tyrosine Kinase-Dependent Engulfment of Apoptotic Cells through a Shared Pathway

  2014cites this paper
• Cellular Injury and Apoptosis

  2014cites this paper
• Nuevo papel de FAS en el control de la proliferación de las células T activadas: implicaciones para la homeostasis inmunológica y el desarrollo de autoinmunidad

  2014cites this paper
• Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis

  2014cites this paper
• Modulation of Strain-Specific Differences in Gene Expression by Cannabinoid Type 2 Receptor Deficiency

  2014cites this paper
• NETs: the missing link between cell death and systemic autoimmune diseases?

  2013cites this paper
• Lupus systémique et dermatomyosites de l’enfant

  2013cites this paper
• C1q but not mannose-binding lectin (Mbl-2) gene polymorphisms are associated with type 2 diabetes in the genetically homogeneous population of the island of Crete in Greece.

  2013cites this paper
• Mannose-binding lectin ( Mbl-2 ) gene polymorphisms are associ ‐ ated with Type 2 diabetes in the genetically homogeneous population of the island of Crete in Greece

  2013cites this paper
• Systemic lupus erythematosus diagnostics in the 'omics' era.

  2013cites this paper
• Homeostasis and Memory T Cell Responses Activated/Memory T Cells and Affects p21CIP1/WAF1 Controls Proliferation of

  2013cites this paper
• 9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus.

  2013cites this paper
• 18 – Innate Immunity

  2013cites this paper
• C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice

  2013cites this paper
• Lupus sistémico y dermatomiositis infantil

  2013cites this paper
• but No Autoimmune Phenotype Display Defective Apoptotic Cell Clearance Mannose-Binding Lectin-Deficient Mice

  2013cites this paper
• -Transgenic Mice α Development of Autoimmunity in IL-14

  2013cites this paper
• Two paradoxes and a surprise on the road to an understanding of systemic lupus erythematosus.

  2012cites this paper
• Depletion of complement does not impact initiation of xenobiotic‐induced autoimmune disease

  2012cites this paper
• C1q and phagocytosis: the perfect complement to a good meal

  2012cites this paper
• Apoptotic cell death and efferocytosis in atherosclerosis.

  2012cites this paper
• Gender differences in autoimmunity associated with exposure to environmental factors.

  2012cites this paper
• Monogenic autoimmunity.

  2012cites this paper
• Absence of CD59 Exacerbates Systemic Autoimmunity in MRL/lpr Mice

  2012cites this paper
• ATVB In Focus Apoptotic Cell Death and Efferocytosis in Atherosclerosis

  2012cites this paper
• Animal models of molecular pathology systemic lupus erythematosus.

  2012cites this paper
• Collectins: Mannan-Binding Protein as a Model Lectin

  2012cites this paper
• Increased red cell turnover in a line of CD22‐deficient mice is caused by Gpi1c: A model for hereditary haemolytic anaemia

  2012cites this paper
• This information is current as Autoimmunity in MRL / lpr Mice Absence of CD 59 Exacerbates Systemic

  2012cites this paper
• Complement and Tissue Injury in SLE

  2011cites this paper
• Entry of Bacillus anthracis spores into epithelial cells is mediated by the spore surface protein BclA, integrin α2β1 and complement component C1q

  2011cites this paper
• Role of Complement Component C1q in the Onset of Preeclampsia in Mice

  2011cites this paper
• Genetic Segregation of Inflammatory Lung Disease and Autoimmune Disease Severity in SHIP-1−/− Mice

  2011cites this paper
• The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice.

  2011cites this paper
• Molecular basis of hereditary C1q deficiency—revisited: identification of several novel disease-causing mutations

  2011cites this paper
• Genetics of Lupus in Mice

  2011cites this paper
• Anti-DNA Antibodies: Structure, Regulation and Pathogenicity

  2011cites this paper
• Next-Generation Computational Genetic Analysis: Multiple Complement Alleles Control Survival after Candida albicans Infection

  2011cites this paper
• Experimental models of lupus nephritis.

  2011cites this paper
• Genetic Susceptibility and Class III Complement Genes

  2011cites this paper
• The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition.

  2011cites this paper
• This information is current as Mice − / − SHIP-1 Disease and Autoimmune Disease Severity in Genetic Segregation of Inflammatory Lung

  2011cites this paper
• Antibody‐Mediated Rejection—An Ounce of Prevention Is Worth a Pound of Cure

  2011cites this paper
• Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.

  2010cites this paper
• C1q Deficiency Leads to the Defective Suppression of IFN-α in Response to Nucleoprotein Containing Immune Complexes

  2010cites this paper
• Containing Immune in Response to α Suppression of IFN-C 1 q Deficiency Leads to the Defective Data

  2010cites this paper
• Homozygosity for a novel mutation in the C1q C chain gene in a Turkish family with hereditary C1q deficiency.

  2010cites this paper
• Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus

  2010cites this paper
• Tolerance: an overview and perspectives

  2010cites this paper